BRIEF-Arcellx Announces Presentation Of New Clinical Data From Its Cart-Ddbcma Phase 1 Trial In Patients With Relapsed Or Refractory Multiple Myeloma At The 64Th Ash Annual Meeting And Exposition

Reuters · 11/03/2022 15:03

Please log in to view news